Paula Chaves da Silva, PhD, is a Post-Doctoral Fellow at the Center for Integration of Science and Industry at Bentley University. She obtained both her PhD and her MS in Morphological Sciences from Federal University of Rio de Janeiro (UFRJ). During her doctorate internship, Dr. Chaves da Silva worked with adult neurogenesis and neurodegenerative events at Wellesley College in Wellesley, MA. In her first post-doctoral role, Dr. Chaves da Silva studied therapeutic strategies to treat neurodegenerative disorders from both basic research and clinical approaches. She obtained a certification in Neurofunctional Physical Therapy from Instituto de Neurologia Deolindo Couto – UFRJ, focusing on strength training in people with Parkinson’s Disease. As a National Science Foundation (NSF) supported Post-Doctoral Fellow in the Neuroscience Department at Wellesley College, Dr. Chaves da Silva managed a project on the relationship between adult neurogenesis and the immune system. Starting at Bentley University in September 2021, her current research focuses on health value created by biopharmaceutical companies, which includes the societal impact of pharmaceutical activity.
Paula G. Chaves da Silva
By this expert
Forget the Posturing – The Inflation Reduction Act May Work Better Than Many Expected
The IRA has the potential to rectify the imbalance between public benefit and private incentives
Considering Returns on Federal Investment in the Negotiated “Maximum Fair Price” of Drugs Under the Inflation Reduction Act: an Analysis
The empirical analysis of public sector investments and the health value created by the drugs selected for Medicare price negotiations provides a cost basis for the assessment of the maximum fair price.